| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $881.0M | — | +23.4% |
| Cost of Revenue | $145.7M | — | +26.6% |
| Gross Profit | $735.3M | — | +22.7% |
| R&D Expense | $234.2M | — | +6.4% |
| SG&A Expense | $85.6M | — | +8.9% |
| Operating Income | $27.9M | — | +201.7% |
| Pre-tax Income | $39.3M | — | +498.2% |
| Income Tax | $6.7M | — | -43.5% |
| Net Income | $32.6M | — | +249.4% |
| EPS (Basic) | $0.62 | — | +247.6% |
| EPS (Diluted) | $0.62 | — | +247.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $943.9M | +7.0% | +51.0% |
| Accounts Receivable | $354.9M | -15.3% | +20.5% |
| Current Assets | $2.44B | -0.3% | -6.6% |
| Total Assets | $3.83B | -0.6% | -1.7% |
| Current Liabilities | $1.52B | +3.4% | -3.8% |
| Total Liabilities | $1.83B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $198.8M | — | +23.1% |
| Capital Expenditures | $15.4M | — | +15.6% |
| Investing Cash Flow | $64.6M | — | +186.2% |
| Financing Cash Flow | -$196.2M | — | -144.2% |
| Free Cash Flow | $183.4M | — | +23.7% |
| -3.1% |
| Stockholders' Equity | $2.00B | -3.4% | -0.4% |